Maternal mortality due to hypertension in Peru during the period 2020-2023
Keywords:
Prenatal care, obstetric complication, obstetric intervention, safe motherhood, gestational monitoring, maternal health.Abstract
Introduction: Maternal mortality is an indicator of excellence in public health.
Objective: To describe maternal mortality due to hypertension in Peru during the period 2020-2023.
Material and Methods: An observational longitudinal study was carried out in January 2024, in Ica, Peru. Maternal deaths were described from 2020 to 2023 until week 18. The population considered was 565 (sample: 110 cases). The initial analysis corresponded to the description by age group (19 years or younger, from 20 to 35 years, and over 35 years), time of occurrence (postpartum, pregnancy, delivery, or unknown events), and hypertensive disorders. Statistical analysis was conducted using SPSS v25.
Results: In 2021, maternal mortality was the highest (44.62%), while in 2020, it was the lowest (31.21%). The 20-35 age group recorded most of the deaths (58%), followed by >35 years (31%) and ≤19 years (11%), respectively. Relative frequencies decreased from 2021 to 2023, with the puerperium as the most critical time (90%). Deaths due to hypertensive disorders decreased from 2021 (23%) to 2023 (18%). Five criteria were proposed to mitigate maternal mortality due to hypertension, including promoting reproductive decision-making and ensuring equitable access to obstetric care, prioritizing early detection of this disorder.
Conclusions: The analysis of maternal mortality in Peru from 2020 to 2023 underscores the urgency of improving obstetric care, accomplishing the early detection of disorders such as hypertension, and promoting equity of access to reproductive health services.
Downloads
References
1. Rondung E, Ekdahl J, Sundin Ö. Potential mechanisms in fear of birth: The role of pain catastrophizing and intolerance of uncertainty. Birth [Internet]. 2019 [Citado 17/09/2023];46(1):61-8. Disponible en: https://doi.org/10.1111/birt.12368
2. Slade P, Balling K, Sheen K, Houghton G. Establishing a valid construct of fear of childbirth: Findings from in-depth interviews with women and midwives. BMC Pregnancy and Childbirth [Internet]. 2019 [Citado 08/10/2023];19(1):96. Disponible en: https://doi.org/10.1186/s12884-019-2241-7
3. Cardwell MS. Stress: pregnancy considerations. Obstetrical & Gynecological Survey [Internet]. 2013 [Citado 13/10/2023];68(2):119-29. Disponible en: https://doi.org/10.1097/ogx.0b013e31827f2481
4. Magee LA, Brown MA, Hall DR, Gupte S, Hennessy A, Karumanchi SA, et al. The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens [Internet]. 2022 [Citado 07/01/2024];27:148-69. Disponible en: https://doi.org/10.1016/j.preghy.2021.09.008
5. Wu P, Green M, Myers JE. Hypertensive disorders of pregnancy. British Medical Journal [Internet]. 2023 [Citado 08/01/2024];381:071653. Disponible en: https://doi.org/10.1136/bmj-2022-071653
6. Ngene NC, Moodley J. Blood pressure measurement in pregnancy and preeclampsia: devices, techniques, and challenges. Cardiovascular Journal of Africa [Internet]. 2019 [Citado 04/12/2023];30(20):120-9. Disponible en: https://doi.org/10.5830/CVJA-2018-067
7. US Preventive Services Task Force, Barry MJ, Nicholson WK, Silverstein M, Cabana MD, Chelmow D, et al. Screening for Hypertensive Disorders of Pregnancy: US Preventive Services Task Force Final Recommendation Statement. Journal of the American Medical Association [Internet]. 2023 [Citado 07/01/2024];330(11):1074-82. Disponible en: https://doi.org/10.1001/jama.2023.16991
8. Magee LA, von Dadelszen P. Intervention to address cardiovascular risk following hypertensive pregnancy. British Journal of Obstetrics and Gynaecology [Internet]. 2023 [Citado 12/01/2024];130(7):727-8. Disponible en: https://doi.org/10.1111/1471- 0528.17421
9. Burger RJ, Delagrange H, van Valkengoed IGM, de Groot CJM, van den Born BH, Gordijn SJ, et al. Hypertensive disorders of pregnancy and cardiovascular disease risk across races and ethnicities: A review. Frontiers in Cardiovascular Medicine [Internet]. 2022 [Citado 10/10/2023];9:933822. Disponible en: https://doi.org/10.3389/fcvm.2022.933822
10. Ngene NC, Moodley J. Pre-delivery angiogenic factors and their association with peripartum perceived stress and pain in pre-eclampsia with severe features and normotensive pregnancies. International Journal of Gynecology & Obstetrics [Internet]. 2022 [Citado 19/11/2023];158(2):398-405. Disponible en: https://doi.org/10.1002/ijgo.13972
11. Guevara RE. La preeclampsia, problema de salud pública. Revista Peruana de Investigación Materno Perinatal [Internet]. 2019 [Citado 12/01/2024];8(2):7-8. Disponible en: https://doi.org/10.33421/inmp.2019147
12. Centro Nacional de Epidemiología, Prevención y Control de Enfermedades. Análisis de situación de salud. Boletín Epidemiológico de Perú [Internet]. 2019 [Citado 07/11/2023];27–SE26. Disponible en: https://www.dge.gob.pe/portal/docs/vigilancia/boletines/2019/26.pdf
13. Ministerio de Salud Pública. Situación Epidemiológica de la Mortalidad Materna en Perú, 2022 - 2023 (SE 18) [Internet]. Perú: Ministerio de Salud Pública; 2023 [Citado 28/03/2024]. Disponible en: https://www.mesadeconcertacion.org.pe/storage/documentos/2023-05-18/cdc-mortalidad-materna-2022-2023.pdf
14. Nava GEN, Nungaray GL, Salcedo A, Cisneros RF, Perales DJ, Durán LA. Morbilidad materna extrema: intervención es médico-quirúrgicas e indicadores para evitar la muerte materna. Revista Ginecología y Obstetricia de México [Internet]. 2020 [Citado 07/042024];88(9):606-14. Disponible en: https://doi.org/10.24245/gom.v88i9.42463
15. Paller L, Feldman F, Lauria W, Rey G. Obstetric and perinatal outcomes in teenage pregnancy: a literature review. International Journal of Family & Community Medicine [Internet]. 2021 [Citado 19/02/2024];5(1):179-83. Disponible en. https://doi.org/10.15406/ijfcm.2021.05.00211
16. Dimitriadis E, Rolnik DL, Zhou W. Pre-eclampsia. Nature Reviews Disease Primers [Internet]. 2023 [Citado 15/01/2024];9(8):36797292. Disponible en: https://doi.org/10.1038/s41572-023-00417-6
17. Bisson C, Dautel S, Patel E, Suresh S, Dauer P, Rana S. Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Frontiers in Medicine (Lausanne) [Internet]. 2023 [Citado 13/01/2024];10:1144170. Disponible en: https://doi.org/10.3389/fmed.2023.1144170
18. Ishmail H, Khaliq OP, Ngene NC. The role of genetics in maternal susceptibility to preeclampsia in women of African ancestry. Journal of Reproductive Immunology [Internet]. 2023 [Citado 05/01/2024];160:104139. Disponible en: https://doi.org/10.1016/j.jri.2023.10413
19. Garrafa E, Levaggi R, Miniaci R, Paolillo C. When fear backfires: Emergency department accesses during the Covid-19 pandemic. Health Policy [Internet]. 2020 [Citado 23/08/2023];124(12):1333-9. Disponible en: https://doi.org/10.1016/j.healthpol.2020.10.006
20. Reinders S, Alva A, Huicho L, Blas MM. Indigenous communities’ responses to the COVID-19 pandemic and consequences for maternal and neonatal health in remote Peruvian Amazon: a qualitative study based on routine programme supervision. BMJ Open [Internet]. 2020 [Citado 19/09/2023];10(12):044197. Disponible en: https://doi.org/10.1136/bmjopen-2020-044197
21. Takemoto MLS, Menezes MO, Andreucci CB, Knobel R, Sousa LAR, Katz L, et al. Maternal mortality and COVID-19. The Journal of Maternal-Fetal & Neonatal Medicine [Internet]. 2020 [Citado 12/12/2023];35(12):2355-61. Disponible en: https://doi.org/10.1080/14767058.2020.1786056
22. Centro Nacional de Epidemiología Prevención y Control de Enfermedades. Muerte Materna [Internet]. Perú: Ministerio de Salud; 2020 [Citado 06/01/2023]. Disponible en: https://www.dge.gob.pe/portal/docs/tools/teleconferencia/2020/SE412020/04.pdf
23. UNFPA. Muertes maternas aumentarán en 40% debido a la pandemia si no se recupera el sistema de salud [Internet]. Perú: UNFPA; 2020 [Citado 07/01/2023]. Disponible en: https://peru.unfpa.org/es/news/muertes-maternas-aumentar%C3%A1n-en-40-debido-la-pandemia-si-no-se-recupera-el-sistema-de-salud